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ABSTRACT:  Hypoglycaemic  activity  of  shilajeet  and  Yashada  Bhasma  was  determined  in 
normoglycaemic and alloxanized rats.  Significant activity was observed in the treated groups. 
However, the activity was found to be comparatively milder in shilajatu treated rats compared to 
yashada bhasma treated rats. 
 
INTRODUCTION  
 
In Ayurvedic literature, shuddh shilajatu has 
been  prescribed  for  a  variety  of  ailments, 
Basically,  it  is  mentioned  as  Naimittika 
Rasayana  for  prameha.  Besides  this, 
Shilajatu  has  also  been  recommended  in 
cases of leprosy, epilepsy obesity, dysuria, 
dyspnoea  and  anaemia  (Caraka).  Certain 
recent  experimental  studies  have 
demonstrated  immunomodulatory  (Ghosal, 
1990)  mast  cell  protecting  (Ghosal  et  al., 
1989), Antiulcerogenic (Goel et al., 1990), 
Anaboilc (Gupta et al., 1966) and memory 
promoting (Gupta et al., 1966) and memory 
promoting (Ghosal et al., 1993) activity in 
shilajatu. Similarly in some Ayurveda texts, 
Yashada Bhasma has been recommended in 
case  of  tuberculosis,  common  cold, 
indigestion,  weakness  and  anaemia  etc 
(Rasatarangini). Besides this, both of these 
mineral  drugs  are  incorporated  in  several 
ayurvedic compounds used for the treatment 
of  prameha  e.g.  Chandra  Prabha  Vati, 
Pramehahara Vati Vrihata somanath RAs. In 
view  of  the  above  facts,  we  investigated 
possible hypoglycaemic activity of shilajatu 
and  yashada  Bhasma  separately  in  normal 
and alloxanised rats. 
MATERIAL AND METHOD 
 
In the present study, thirty adult albino rats 
(C.F  strain),  weighing  200  ±  20gm  each 
were  used.    The  rats  were  housed  in 
polypropylene cages (5 in each cage).  These 
animals  were  fed  commercial  rat  feed  and 
water ad lib. The rats were divided in three 
groups  of  each.  Group  I-  The  rate  of  this 
group were used as control. Group II – Each 
rat of this group was administered  shuddh 
shilajatu (250 mg/Kg. bw.,  orally) through 
gavage once daily for 15 days.  Group III the 
animals  of  this  group  were  given 
commercially  available  Yashada  Bhasma 
(100  mg/Kg.  b.w.p.o)  once  daily  for  15 
days. At the end of 15 days, blood from the 
retro orbital venous plexus of each rat was 
collected following overnight fasting. These 
blood  samples  were  used  for  the 
determination  of  blood  sugar  levels  using 
oxidase  peroxidase  methods  (Trinder 
(1969). 
 
Effect on Alloxanised Rats: 
 
A  total  of  thirty  albino  rats  (c.f.  strain) 
weighing 200 ± 20gm were equally divided 
into  three  groups.  Group  I-  rats  served  as 
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administered shilajeet (250 mg/kg. b.w.p.o) 
and Yashada Bhasma (100 mg/kg b.w.p.o) 
respectively for 10 days. Thereafter, all rats 
of control and treated groups were injected 
alloxan (150mg/kg. b.w 1/p Sigma) after 36 
hours  of  fasting;  the  administration  of 
yashada Bhasma and shilajeet was continued 
for one week after alloxalization. At the end 
of 17 days blood  from  rats of control  and 
pretreated alloxanised groups was collected 
individually  from  retro  orbital  plexus, 
following overnight fasting, the blood sugar 
estimation  was  done  using  the  method 
described earlier. The data was statistically 
analyzed using student’s ‘t’ test. 
 
RESULTS  
 
In normoglycaemic rats, the administration 
of  Yashada  Bhasma  for  15  Days 
significantly  decreased  the  fasting  blood 
sugar levels (P<.01) (Table – 1). Similarly, 
the  fasting  blood  sugar  levels  were  also 
observed  to  be  lower  in  Yashada  bhasma 
pretreated  alloxanized  rats  as  compared  to 
control alloxanized rats (P<.05) Table -2). 
 
Shilajatu  treated  animals  exhibited 
significant hypoglycaemic activity in normal 
rats (P<.05) as compared to controls (Table 
30). The blood sugar levels were decreased 
in shilajatu pretreated alloxanized rats than 
the normal alloxanized rats (Table 4). 
 
Thus,  the  observation  recorded  in  the 
present  investigations  suggest  that  both 
Yashada  Bhasma  and  Shilajatu  possess 
hypoglycaemic  activity.  However,  such 
activity  is  relatively  more  pronounced  in 
Yashada  bhasma  treated  rates  than  the 
shilajatu  treated  ones.  Similar  to  our 
observations, Prasad and sharma (1989) also 
demonstrated  hypoglycaemic  activity  of 
Yashada  Bhasma  in  rats.  Since,  Yashada 
Bhasma  and  shilajatu  are  used  along  with 
many other drugs in a number of Ayurvedic 
antidiabetic  compounds,  it  appears  that 
synergism among various constituents might 
be  responsible  for  antidiabetic  effects  of 
these  compounds  rather  than  the 
hypoglycaemic  activity  of  individual 
constituents. 
 
Table  - 1: Effect of Yashad Bhasma (100 mg/kg b.w) on fasting blood sugar in normoglycaemic 
rats. (Mean ± S.E) 
 
Control (10)            Yashada Treated (10) 
 
60.2  51.905 
±2.134             ±1.486 
Calculated Student’s ‘t’    =    3.192 
Tabular t 18        =    2.88 
P<.01     Significant at 1% probability.  
  
Table  - 2: Lowering of fasting blood sugar levels in Yashad Bhasma Pretreated alloxanised rats  
as compared to controls. (Mean ± S.E) 
 
Control (10)            Yashada Treated alloxanised (10) 
 
388.86             359.01 
±8.61              ±11.04 
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Tabular t 18        =    2.10 
P<.05     Significant at 5% level of probability.  
 
 
Table  - 3: Effect of (250 mg/kg b.w) on fasting blood sugar in normoglycaemic rats. (Mean ±  
S.E) 
 
Control (10)          Yashada Treated (10) 
 
60.2              54.299 
±2.134             ±1.576 
Calculated Student’s‘t’    =    2.22 
Tabular t 18        =    2.10 
P<.05     Significant at 5% level of probability.  
  
Table  - 4: Lowering of fasting blood sugar in shilajatu Pretreated alloxanised rats (250 mg/kg 
b.w) (Mean ± S.E) 
 
Control (10)             shilajatu Pretreated alloxanised (10) 
 
388.86             359.01 
±8.61              ± 8.5 
Calculated Student’s ‘t’    =    2.46 
Tabular t 18        =    2.10 
P<.05     Significant at 5% level of probability.  
 
REFERENCES 
 
1.  Caraka samhita, Chaukhamba Sanskrit sansthana. 
 
2.  Ghosal,  S.,  Lal,  J.,Singh,  S.K.,  Dasgupta,  G.,  Bhaduri,  J.,  Mukhopadhyay,  M  and 
Bhattacharya, S.K (1989), Phytotherapy Research 3, 249-252. 
 
3.  Ghosal, S., Pure and Applied Chem. (IUPAC) 62, 1285-1288, (1990) 
 
4.  Ghosal, S. Lal, J., Jaiswal, A.K and Bhattacharya, S.K (1993) Phytotherapy Research, 
Vol 7, 29-34 (1993). 
 
5.  Goel, R.K Banerjee, R.S and Acharya, S.B Ethonopharmacol. 29, 95-103 (1990). 
 
6.   Gupta, S.B., Seth, C.B and Mathur, V.S., Physiol, Pharmacol. 4, 182- 185 (1966) 
 
7.  Prasad C.M. and Sharma A.V., Ancient science of life Vol IX, No 2, October 1989, 
Pages 69-70 (1989).     
Pages 118 - 121